Skip to main content
. Author manuscript; available in PMC: 2010 Dec 27.
Published in final edited form as: Sci Transl Med. 2010 May 26;2(33):33ra37. doi: 10.1126/scitranslmed.3001006

Table 2. Metabolite changes in plasma at the peak exercise time point.

Metabolites with P<0.005 in the derivation cohort are shown. Metabolites with identical retention times and parent-daughter ion pairs (e.g. isoleucine and leucine) cannot be distinguished by the platform

Metabolite Derivation Cohort N= 45 % CHANGE (IQR) P value Validation Cohort N=30 % CHANGE (IQR) P value
Lactate 394 (263, 697) <0.0001 553 (332, 697) <0.0001
Malate 120 (63, 232) <0.0001 143 (96, 203) <0.0001
Succinate 246 (125, 379) <0.0001 345 (217, 492) <0.0001
Glycerol 59 (31, 126) <0.0001 50.8 (25, 117) 0.0001
Fumarate 56 (31, 83) <0.0001 75 (47, 133) <0.0001
Pyruvate 169 (78, 308) <0.0001 169 (96, 289) <0.0001
Niacinamide 79 (42, 182) <0.0001 71(11, 148) 0.0005
Pantothenate 22 (1, 64) <0.0001 29 (9, 86) 0.0003
Glucose-6-phosphate 20 (34, 46) <0.0001 25 (11, 74) 0.002
Alanine 29 (-1, 49) <0.0001 30 (3, 41) 0.0008
Inosine 83 (7, 181) <0.0001 68 (15, 250) 0.0005
Hypoxanthine 87 (31, 201) <0.0001 132 (68, 295) <0.0001
Citrulline -8 (-19, -0.6) 0.0003 -12 (-19, -2.8) 0.021
AMP 37(-10, 75) 0.0002 56 (10, 125) 0.004
Isoleucine/Leucine 3(-1, 10) 0.0005 9 (3, 17) 0.0005
Serine -14 (-25, -5) 0.0006 -11 (-22, -3) 0.0061
Glutamate -13 (-27, 0) 0.001 -10 (-30, 16) 0.21
Xanthine 18 (-5.0, 46) 0.002 14 (7, 66) 0.002
Cysteine -19 (-34.5, 8.2) 0.002 -22 (-36, -15.0) 0.0001
Allantoin -28 (-44, -7.4) 0.003 -15 (-28, 2.5) 0.02
3-Phosphoglycerate 26 (-5, 43) 0.0035 34 (-12, 67) 0.06
Homocysteine -14 (-21, 4.2) 0.0039 -15 (-24, 2.6) 0.022
Glutamine 8 (1, 17) 0.004 6 (-4, 14.3) 0.046